Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes heavily influenced by the inflammatory response. This response, triggered by ...

The U.S. Biomarker Testing Market is estimated to be worth USD 11.67 billion in 2025 and is projected to increase at a compound annual growth rate (CAGR) of 2.25% from 2026 to 2035, reaching USD 14.57 ...

Drug development involves significant risk and expense. With average development costs topping $1 billion per approved medicine and stubbornly high failure rates, pharmaceutical leaders are ...

A new review argues that most ICU biomarkers still guide treatment rather than select it, and that no true companion ...

The Foundation for the National Institutes of Health Biomarkers Consortium is celebrating two decades of advancing biomarker science to enable earlier interventions, personalized medicine and improved ...

Daryl Pritchard, PhD, discusses the challenges to implementing biomarker testing that would advance precision medicine and improve patient outcomes in oncology. Access to precision medicine through ...

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate diagnoses for heart failure, in both women and men. Heart failure affects ...

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication in the journal Nature Medicine, they describe the discovery of a new ...

Biomarker testing is booming, with memberships promising deeper health insights, earlier risk detection and more control over ...

The tests will be financed as a hospital care procedure. Their number and prices are yet to be negotiated with the Bulgarian Medical Association ...

Beyond DNA-centric diagnostics, protein-based methods may play a role in accurately matching patients with the most effective therapies. Regarding finding the right drug for the right patient, the ...